Caricamento...
Is suvorexant a better choice than alternative hypnotics?
Suvorexant is a novel dual orexin receptor antagonist (DORA) newly introduced in the U.S. as a hypnotic, but no claim of superiority over other hypnotics has been offered. The manufacturer argued that the 5 and 10 mg starting doses recommended by the FDA might be ineffective. The manufacturer'...
Salvato in:
| Pubblicato in: | F1000Res |
|---|---|
| Autore principale: | |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
F1000Research
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4648222/ https://ncbi.nlm.nih.gov/pubmed/26594338 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.6845.1 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|